Publications

Journal of Clinical Microbiology, 52(5), 1 May 2014, pp 1741-44, doi: 10.1128/JCM.03614-13
Intensive Care Medicine, 40(4), 1 April 2014, pp 564–571, doi: 10.1007/s00134-014-3225-8
Expert Opinion on Therapeutic Targets, 18(8), 1 August 2014, pp 851-61, doi: 10.1517/14728222.2014.925881

Project Partners

R-GNOSIS is coordinated by Marc Bonten (UMC Utrecht) and brings together a multidisciplinary team with complementary expertise of clinicians, microbiologists and epidemiologists, infectious disease specialists, caregivers in inpatient care and mathematical modellers. The R-GNOSIS consortium is made of 19 partners from 9 countries which include United Kingdom, Denmark, Germany, Netherlands, Belgium, France, Spain, Switzerland and Israel.

Tel Aviv Sourasky Medical Center, TASMC, IL

Tel Aviv Sourasky Medical Center, TASMC, IL


Further Information :

Organizational Activities

Tel Aviv Sourasky Medical Centre is a 1200-bed Tertiary care teaching hospital, serving a population of approximately 1,000,000. The Foundation for Medical Research, Infrastructure Development and Health Services is a separate legal entity established and dully registered under the Israeli law it is authorized to perform and execute researches in the Tel-Aviv Sourasky Medical Centre whilst using its facilities.  The project will be carried out by the Division of Epidemiology which has as a major task to improve our understanding of the development and spread of antimicrobial resistance, and thereby to design measures and adopt strategies to combat it.

Role in the Project

Key Personnel

Tel Aviv Sourasky Medical Centre is a 1200-bed Tertiary care teaching hospital, serving a population of approximately 1,000,000. The Foundation for Medical Research, Infrastructure Development and Health Services is a separate legal entity established and dully registered under the Israeli law it is authorized to perform and execute researches in the Tel-Aviv Sourasky Medical Centre whilst using its facilities.  The project will be carried out by the Division of Epidemiology which has as a major task to improve our understanding of the development and spread of antimicrobial resistance, and thereby to design measures and adopt strategies to combat it. - no image description is available -